title: Axillary lymph node management in breast cancer with positive sentinel lymph node biopsy.
abstract: The surgical treatment of localized breast cancer has become progressively less aggressive over the years. The management of the axillary lymph nodes has been modified by the introduction of sentinel lymph node biopsy. Axillary dissection can be avoided in patients with sentinel lymph node negative biopsies. Based on randomized trials data, it has been proposed that no lymph node dissection should be carried out even in certain patients with sentinel lymph node positive biopsies. This commentary discusses the basis of such recommendations and cautions against a general omission of lymph node dissection in breast cancer patients with positive sentinel lymph node biopsies. Instead, an individualized approach based on axillary tumor burden and biology of the cancer should be considered.
authors: Ioannis A Voutsadakis, Silvana Spadafora, Division of Medical Oncology, Department of Internal Medicine, Sault Area Hospital, Sault Ste. Marie, Ontario ON P6B 0A8, Canada.
authors: Ioannis A
authors: IA
authors: Voutsadakis
authors: Ioannis A Voutsadakis, Silvana Spadafora, Division of Medical Oncology, Department of Internal Medicine, Sault Area Hospital, Sault Ste. Marie, Ontario ON P6B 0A8, Canada.
authors: Silvana
authors: S
authors: Spadafora
keywords: Axillary lymph node dissection; Axillary recurrence; Breast cancer; Macro-metastatic; Micro-metastatic; Node positive; Tumor sub-types